Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Could Synthetic Data Predict Rare Adverse Events?

Accenture Surveys Tech Trends In Life Sciences

Aug 22 2022

• By Alaric DeArment

Wireframe DNA sequence molecules structure mesh. Hands of robot and human touching on DNA connecting in virtual interface on future. Artificial intelligence technology concept. Vector illustration. — Accenture released its 2022 tech trends report on 22 August • Source: Shutterstock

Related Content

Validation Issues Could Dull Synthetic Data Benefits

Feb 02 2021

The Russian-Born CRO Leader Trying To Keep Clinical Trials Going In Ukraine

Mar 24 2022

Sanofi Looks To Atomwise For More AI Help

Aug 17 2022

Exscientia And Sanofi Will Search For 15 Novel Oncology, Immunology Drugs Under New Pact

Jan 07 2022

Related Companies

Verily

Sanofi

Atomwise, Inc.

Exscientia plc

Amgen, Inc.

Generate:Biomedicines

Additional Topics

Artificial Intelligence Clinical Trials Business Strategies Research & Development BioPharmaceutical

More from AI

More from Digital Technologies

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window